JUST IN
You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 01 Jul 394.00 7.00
(1.81%)
OPEN

390.50

 HIGH

394.50

 LOW

382.05
NSE 00:00 | 01 Jul 394.10 7.75
(2.01%)
OPEN

385.20

 HIGH

395.00

 LOW

382.00
Add to Watchlist  |   Add to Portfolio
OPEN 390.50
PREVIOUS CLOSE 387.00
VOLUME 29078
52-Week high 690.60
52-Week low 348.90
P/E 6.77
Mkt Cap.(Rs cr) 11,119
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 390.50
CLOSE 387.00
VOLUME 29078
52-Week high 690.60
52-Week low 348.90
P/E 6.77
Mkt Cap.(Rs cr) 11,119
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   11,119
EPS - TTM () [*S] 58.23
P/E Ratio (X) [*S] 6.77
Face Value ()   1
Latest Dividend (%)   250.00
Latest Dividend Date 08 Sep 2021
Dividend Yield (%) 0.00
Book Value / Share () [*S] 593.21
P/B Ratio () [*S] 0.66
[*C] Consolidated     [*S] Standalone    

News

Announcement

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Mar 2022 Mar 2021 % Chg
Net Sales 3019.15 2859.9 5.57
Other Income 107.2 8.49 1162.66
Total Income 3126.35 2868.39 8.99
Total Expenses 2638.28 2336.47 12.92
Operating Profit 488.07 531.92 -8.24
Net Profit 172.57 233.87 -26.21
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
J B Chem & Pharm 1568.85 0.01 12127.21
Natco Pharma 650.70 0.49 11878.53
Suven Pharma 461.60 -0.08 11752.34
Glenmark Pharma. 394.00 1.81 11118.68
ERIS Lifescience 653.05 -1.97 8881.48
Granules India 278.50 2.09 6906.80
P & G Health Ltd 4151.35 -0.86 6891.24
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.65
Banks/FIs 0.44
FIIs 24.12
Insurance 0.00
Mutual Funds 6.18
Indian Public 15.88
Custodians 0.00
Other 2.39
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
25/06/2021 Nirmal Bang Not Rated 639 PDF IconDetails
19/08/2020 Nirmal Bang Accumulate 481 PDF IconDetails
19/08/2020 Elara Capital Accumulate 481 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 2.67% 2.59% 0.34% 0.34%
1 Month 1.30% 1.34% -4.47% -4.66%
3 Month -12.88% -12.88% -10.74% -10.86%
6 Month -25.42% -25.44% -9.18% -9.23%
1 Year -39.66% -39.66% 1.13% 0.46%
3 Year -10.71% -10.69% 33.31% 32.75%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 382.05
394.50
Week Low/High 374.80
396.00
Month Low/High 348.90
402.00
YEAR Low/High 348.90
691.00
All TIME Low/High 1.89
1262.00

Browse STOCK Companies

Quick Links for Glenmark Pharmaceuticals:

.